Literature DB >> 10087988

Commentary: low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease.

D Elstein1, A Abrahamov, M Itzchaki, A Zimran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10087988     DOI： 10.1006/bcmd.1998.0196

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   3.039


× No keyword cloud information.
  2 in total

Review 1.  Gaucher disease: pediatric concerns.

Authors:  Deborah Elstein; Aya Abrahamov; Altoon Dweck; Irith Hadas-Halpern; Ari Zimran
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Current and emerging pharmacotherapy for Gaucher disease in pediatric populations.

Authors:  Richard Sam; Emory Ryan; Emily Daykin; Ellen Sidransky
Journal:  Expert Opin Pharmacother       Date:  2021-03-25       Impact factor: 4.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.